These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 10707575
1. [Insulin resistance in pituitary, thyroid, and adrenal diseases]. Iitaka M, Katayama S. Nihon Rinsho; 2000 Feb; 58(2):451-5. PubMed ID: 10707575 [Abstract] [Full Text] [Related]
2. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E, Minuto F, Colao A, Ferone D. Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [Abstract] [Full Text] [Related]
3. Correction of insulin resistance in methimazole-treated patients with Graves disease. Tene C, Zárate A, Basurto L, Islas S, Revilla C, Ochoa R, Galván R, Santos P. Rev Invest Clin; 2001 Jun; 53(6):531-5. PubMed ID: 11921526 [Abstract] [Full Text] [Related]
4. Hormonal diagnosis of GH hypersecretory states. Grottoli S, Gasco V, Ragazzoni F, Ghigo E. J Endocrinol Invest; 2003 Jun; 26(10 Suppl):27-35. PubMed ID: 15497657 [Abstract] [Full Text] [Related]
5. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM. Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047 [Abstract] [Full Text] [Related]
6. Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface. Dimitriadis G, Maratou E, Alevizaki M, Boutati E, Psara K, Papasteriades C, Raptis SA. Horm Metab Res; 2005 Jan; 37(1):15-20. PubMed ID: 15702433 [Abstract] [Full Text] [Related]
10. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A, Murray RD, Teasdale GM, Shalet SM. Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [Abstract] [Full Text] [Related]
15. CRH in Cushing's syndrome. Müller OA, Stalla GK, von Werder K. Horm Metab Res Suppl; 1987 Apr 15; 16():51-8. PubMed ID: 2832289 [Abstract] [Full Text] [Related]
16. Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts. Kausch C, Bergemann C, Hamann A, Matthaei S. Exp Clin Endocrinol Diabetes; 1999 Apr 15; 107(2):148-54. PubMed ID: 10320056 [Abstract] [Full Text] [Related]
18. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly? Foltyn W, Kos-Kudla B, Strzelczyk J, Matyja V, Karpe J, Rudnik A, Marek B, Kajdaniuk D, Sieron A, Latos W. Neuro Endocrinol Lett; 2008 Feb 15; 29(1):107-12. PubMed ID: 18283256 [Abstract] [Full Text] [Related]
19. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis. Luque RM, Gahete MD, Valentine RJ, Kineman RD. J Mol Endocrinol; 2006 Aug 15; 37(1):25-38. PubMed ID: 16901921 [Abstract] [Full Text] [Related]